N-Ras

N-Ras is a small GTPase that controls cell proliferation, differentiation, and survival through GDP/GTP-regulated signaling^[1]. Mechanistically, Ras proteins cycle between ON and OFF states and signal through effector pathways including RAF-MEK-ERK and PI3K^[2][3]. In disease models, NRAS has strong relevance in melanoma and acute myelogenous leukemia, and NRAS-mutant melanoma depends on MAPK and PI3K/mTOR signaling^[4][5]. Compared with related isoforms, N-Ras, K-Ras, and H-Ras share high G-domain conservation, but biochemical studies show distinct catalytic and signaling properties, so H-Ras data should not be treated as fully representative of N-Ras^[1][6]. Isoform distinction also matters experimentally because KRAS is usually more abundant than NRAS in cell-line panels, whereas NRAS often exceeds HRAS in those models^[7]. For applications, MEK inhibition with binimetinib improved progression-free survival versus dacarbazine in advanced NRAS-mutant melanoma, while combined MEK and PI3K/mTOR targeting showed antitumor activity in NRAS-mutant melanoma models^[8][5]. Recent NRAS-directed monobody work further supports direct inhibition and degradation strategies for NRAS-focused research tools^[9].